Crane Company (CR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
1 Apr, 2026Executive summary
Achieved record financial and operational results in 2025, with 13% sales growth in Aerospace & Advanced Technologies and 5% in Process Flow Technologies, driven by organic growth, acquisitions, and portfolio transformation.
Completed major acquisitions, including Panametrics, Druck, and Reuter-Stokes for $1.06 billion, and optek-Danulat, enhancing capabilities in both core segments.
Divested Engineered Materials segment to focus on two strategic growth platforms.
Increased combined equity value by approximately $9 billion since 2022, a 157% rise.
Voting matters and shareholder proposals
Stockholders will vote on: (1) election of nine directors for one-year terms, (2) ratification of Deloitte & Touche LLP as independent auditors for 2026, and (3) a non-binding advisory vote on executive compensation.
Board recommends voting FOR all proposals.
Board of directors and corporate governance
Board consists of nine members, eight of whom are independent; will expand to ten with incoming CEO Alcala.
Board rejected resignation of Lead Independent Director Tullis, citing his value during CEO transition.
Board committees (Audit, Compensation, Nominating/Governance) are 100% independent.
Annual board and committee self-evaluations, director retirement and overboarding policies, and majority voting with resignation policy in place.
CEO succession plan executed: Alcala to become CEO after Annual Meeting, Mitchell to transition to Executive Chairman.
Latest events from Crane Company
- Proxy details director elections, auditor ratification, and strong 2024 performance with robust governance.CR
Proxy filing1 Apr 2026 - Annual meeting to vote on directors, auditor, and pay, with online and eco-friendly options.CR
Proxy filing1 Apr 2026 - Annual meeting to vote on directors, auditor, and executive pay, with board support for all.CR
Proxy filing1 Apr 2026 - Q3 2025 delivered 7.5% sales growth, 27% higher EPS, and a raised full-year outlook.CR
Q3 20253 Feb 2026 - Record 2025 growth and acquisitions set up 10% adjusted EPS growth for 2026.CR
Q4 20252 Feb 2026 - Q2 sales up 14% and adjusted EPS up 18%, with raised full-year guidance and strong segment growth.CR
Q2 20242 Feb 2026 - Q3 2024 saw 13% sales growth, 34% higher EPS, and raised full-year guidance.CR
Q3 202418 Jan 2026 - Q4 adjusted EPS up 58%, sales up 12%, and 2025 guidance raised with a 12% dividend increase.CR
Q4 20249 Jan 2026 - Strong growth, margin expansion, and disciplined M&A set the stage for doubling business size.CR
Gabelli Funds 35th Annual Pump, Valve & Water Symposium7 Jan 2026